Loading insider details...
Beta
Latest Form 4 (Feb 12, 2026): Grant/Award of 203,851 AARD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 12, 2026 | Aardvark Therapeutics, Inc. (AARD) | Grant/Award | 203,851 | n/a |
| Dec 13, 2025 | Aardvark Therapeutics, Inc. (AARD) | Purchase | 7,000 | $101.4K |
| Oct 16, 2025 | Aardvark Therapeutics, Inc. (AARD) | Exercise/Conversion | 1,229 | $5.2K |
| Sep 16, 2025 | Aardvark Therapeutics, Inc. (AARD) | Purchase | 6,500 | $61.8K |
| Sep 13, 2025 | Aardvark Therapeutics, Inc. (AARD) | Purchase | 9,000 | $71.2K |
| Aug 29, 2025 | Aardvark Therapeutics, Inc. (AARD) | Exercise/Conversion | 17,209 | $73.0K |
| Jun 13, 2025 | Aardvark Therapeutics, Inc. (AARD) | Grant/Award | 549,534 | n/a |
| Feb 19, 2025 | Aardvark Therapeutics, Inc. (AARD) | Conversion | 41,303 | n/a |
| Jan 17, 2023 | Scilex Holding Co (SCLX) | Grant/Award | 250,000 | n/a |